Vaccination after recovery from COVID-19 reduced rate of reinfection by half
1. Completion of the primary vaccination series against COVID-19 amongst individuals who had previously recovered from the infection reduced the...
COVID-19 Classics
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
Third dose of BNT162b2 COVID-19 vaccine effective at decreasing risk of hospitalization [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
Inactivated whole-virion SARS-CoV-2 vaccine reduces rates of symptomatic COVID-19 infections [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
Heparin in noncritically ill COVID-19 patients [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
Interleukin-6 receptor antagonist treatment improves outcomes in patients with COVID-19 infection [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
The RECOVERY trial: Dexamethasone decreased mortality in hospitalized COVID-19 patients [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
Nationwide vaccination campaign with BNT162b2 mRNA vaccine reports high immunogenicity across all age groups [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
The EMPACTA trial: Tocilizumab reduced COVID-19 disease-related adverse health outcomes [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
The COVE trial: mRNA-1273 vaccine for preventing COVID-19 [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
